Latest From Sagimet Biosciences
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced January and February 2019.
Bharat hopes to expand international reach of Chiron Behring’s rabies vaccine. WuXi and Biolingus partner on sublingual delivery.
News of 5AM's two latest venture funds follows the launch of Longevity Vision Fund as well as LA BioMed's and RUNLABS’ announcements that they will open new incubators in 2019. Also, Passage Bio launches with $115.5m, but the largest recent VC deal was HaiHe's $146.6m financing.
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
- Therapeutic Areas
- Hepatic (Liver)
- 3-V Biosciences Inc.
- North America
- Parent & Subsidiaries
- Sagimet Biosciences
- Senior Management
George Kemble, PhD, CEO & CSO
William McCulloch, CMO
- Contact Info
Phone: (650) 561-8600
3715 Haven Ave.
Menlo Park, CA 94025
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.